Diseases of the Colon & Rectum

, Volume 48, Issue 7, pp 1416–1423 | Cite as

A Phase I Clinical Trial of the Treatment of Crohn’s Fistula by Adipose Mesenchymal Stem Cell Transplantation

  • Damián García-OlmoEmail author
  • Mariano García-Arranz
  • Dolores Herreros
  • Isabel Pascual
  • Concepción Peiro
  • José Antonio Rodríguez-Montes
Original Contribution


The effective management of fistulas in patients with Crohn’s disease presents an extremely challenging problem. Mesenchymal adult stem cells extracted from certain tissues, such as adipose tissue, can differentiate into various cell types. Therefore, we have tried to use such cells to stimulate healing of Crohn’s fistulas.


We designed a prospective Phase I clinical trial, involving five patients with Crohn’s disease, to test the feasibility and safety of autologous stem cells transplantation in the treatment of fistulas. We also studied the expression of various cell markers and the growth rates of the lipoaspirate-derived cells that were used for transplantation.


One patient was excluded because of bacterial contamination of cultured cells. We inoculated nine fistulas in four patients with autologous adipose tissue-derived stem cells at Passage 3 or earlier. Eight inoculated fistulas were followed weekly for at least eight weeks. In six fistulas, the external opening was covered with epithelium at the end of Week 8, and, thus, these fistulas were considered healed (75 percent). In the other two fistulas, there was only incomplete closure of the external opening, with a decrease in output flow (not healed; 25 percent). No adverse effects were observed in any patient at the end of the follow-up period (minimum follow-up,12 months; maximum follow-up, 30 months; follow-up average, 22 months).


To our knowledge, this is the first report of a clinical trial of cell therapy using autologous stem cells obtained from a lipoaspirate. Our results indicate that our protocol is feasible and safe for the treatment of fistulas in Crohn’s disease. The number of patients included and the uncontrolled nature of Phase I clinical trials do not allow demonstration of the effectiveness of the treatment. However, the results of the present study encourage to perform further studies in Phase II.

Key words

Crohn’s fistula Stem cell Clinical trial 



The authors thank Dolores Garcia-Olmo, Ph.D., Chief of the Research Unit, (Albacete General Hospital-Spain) and Paloma De-La-Quintana, stomatherapist nurse (La Paz University Hospital-Madrid-Spain), for their useful collaboration during the development of this study, and C. F. Sánchez-Ferrer, Department of Pharmacology (U.A.M.), for providing us with the room and part of the material to perform some of the indirect immunofluorescence assays.


  1. 1.
    American Gastroenterological Association Clinical Practice Committee2003American Gastroenterological Association medical position statement: perianal Crohn’s diseaseGastroenterology12515037Google Scholar
  2. 2.
    Levy, C, Tremaine, WJ 2002Management of internal fistulas in Crohn’s diseaseInflamm Bowel Dis810611PubMedGoogle Scholar
  3. 3.
    Penninckc, F, D’Hoore, A, Filez, L 2001Advancement flap plasty for the closure of anal and recto-vaginal fistulas in Crohn’s diseaseActa Gastroenterol Belg642236PubMedGoogle Scholar
  4. 4.
    Rius, J, Nessim, A, Nogueras, JJ, Wexner, SD 2000Gracilis transposition in complicated perianal fistula and unhealed perineal wounds in Crohn’s diseaseEur J Surg16621822PubMedGoogle Scholar
  5. 5.
    Mizuno, H, Zuk, PA, Zhu, M, Lorenz, HP, Benhaim, P, Hedrick, MH 2002Myogenic differentiation by human processed lipoaspirate cellsPlast Reconstr Surg109199209PubMedGoogle Scholar
  6. 6.
    Zuk, PA, Zhu, M, Mizuno, H,  et al. 2001Multilineage cells from human adipose tissue: implications for cell-based therapiesTissue Eng721128PubMedGoogle Scholar
  7. 7.
    García-Olmo, D, García-Arranz, M, Gomez-García, L,  et al. 2003Autologous stem-cell transplantation for treatment of recto-vaginal fistula in perianal Crohn’s disease: a new cell-based therapyInt J Colorectal Dis184514PubMedGoogle Scholar
  8. 8.
    Abkowitz, JL 2002Can human hematopoietic stem cells become skin, gut or liver cells?N Engl J Med3467702PubMedGoogle Scholar
  9. 9.
    Matsubara, H 2004Risk of the coronary arteries of intracoronary stem cells infusion G-CSF cytokine therapyLancet3637467PubMedGoogle Scholar
  10. 10.
    Cowan, CM, Shi, YY, Aalami, OO,  et al. 2004Adipose-derived adult stromal cells heal critical-size mouse calvarial defectsNat Biotechnol225607PubMedGoogle Scholar
  11. 11.
    García-Olmo, D, García-Olmo, MA 2003The vulture and stem cellsN Engl J Med34914801PubMedGoogle Scholar

Copyright information

© The American Society of Colon and Rectal Surgeons 2005

Authors and Affiliations

  • Damián García-Olmo
    • 1
    • 2
    • 3
    Email author
  • Mariano García-Arranz
    • 2
  • Dolores Herreros
    • 1
    • 2
  • Isabel Pascual
    • 1
    • 2
  • Concepción Peiro
    • 4
  • José Antonio Rodríguez-Montes
    • 1
    • 3
  1. 1.Department of General Surgery“La Paz” University HospitalMadridSpain
  2. 2.Cell Therapy Laboratory“La Paz” University HospitalMadridSpain
  3. 3.Department of SurgeryUniversidad Autónoma de MadridMadridSpain
  4. 4.Department of Pharmacology and Therapeutics“La Paz” University HospitalMadridSpain

Personalised recommendations